𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Concurrent development of resistance to 6-azauridine and adenosine in a mouse cell line

✍ Scribed by S. Hashmi; S. R. May; R. S. Krooth; O. J. Miller


Publisher
John Wiley and Sons
Year
1975
Tongue
English
Weight
715 KB
Volume
86
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A variant of the hypoxanthine‐guanine phosphoribosyltransferase deficient, and adenine phosphoribosyltransferase deficient mouse A9 cell line has been obtained by selecting cells which are resistant to 6‐azauridine. These cells are not only resistant to 6‐azauridine (5 × 10^−4^ M), but also to adenosine (10^−3^ M). Resistance persists indefinitely even in the absence of both compounds. The resistant cells are killed by 5‐fluorouridine (10^−6^ M), indicating that the part of the salvage pathway for pyrimidine ribonucleotide biosynthesis which is relevant to the action of 6‐azauridine is intact. The heritable change producing concurrent resistance to 6‐azauridine and adenosine probably involves the de novo pyrimidine biosynthetic pathway.


📜 SIMILAR VOLUMES


Immunological characterization of metall
✍ Indu Maiti; Majambu Mbikay; Claude Marengo; Jean-Paul Thirion 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

## Abstract A cadmium‐resistant variant isolated from mouse fibroblast LMTK cells can grow in the presence of 40 μM Cd^2+^. This variant retained its properties in the absence of selecting agent. Induction of metallothionein was measured in cell extracts by radioimmunoassay. The maximum amount of m

Mechanism of resistance to cisplatin in
✍ Faina Vikhanskaya; Luana Clerico; Monica Valenti; Maria S. Stanzione; Massimo Br 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 99 KB 👁 2 views

A possible novel mechanism of cross-resistance to cisplatin (CDDP) in the doxorubicin-resistant ovarian-cancer cell line A2780-DX3, which displays atypical multidrug resistance, is presented. A2780-DX3 is found to be more resistant than the parental line A2780 in terms of CDDP-induced cytotoxicity a

Actinomycin-D-resistant in vitro mouse c
✍ J. Belehradek Jr.; J. L. Biedler; M. Thonier; G. Barski 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 French ⚖ 761 KB

## Abstract The tumorigenic EPO clonal cell line, derived from a methylcholanthrene‐induced murine sarcoma, was exposed to increasing concentrations of actinomycin D and gave rise to a subline, resistant to 0.02 μg of actinomycin D per ml of medium, which was designated EPO/ADj. Drug resistance was

Mechanism of cross-resistance to cisplat
✍ Shivendra V. Singh; Bing H. Xu; Jitesh P. Jani; Erling O. Emerson; Mary G. Backe 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 730 KB

This study was undertaken to elucidate the mechanism@) of cross-resistance to cisplatin (CDDP) in a mitomycin C (MMC)resistant human bladder cancer cell line, J82/MMC. The J82/ MMC cell line displayed 2-to 3-fold cross-resistance to CDDP and carboplatin when compared to the parental )82/WT cells. Dr

Other transgenic mutation assays: Develo
✍ Vasily N. Dobrovolsky; Daniel A. Casciano; Robert H. Heflich 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 663 KB

A tk+/mouse embryonic stem (ES) cell line, designated 1G2, has been created in which one allele of the thymidine kinase (tk) gene was inactivated by targeted homologous recombination. This line is an analog of the mouse lymphoma tk+/-L5 178Y cell line, which is used widely to assess the mutagenicity